Onderneming Beleave Inc. Canadian Securities Exchange
Aandelen
BE
CA0775611084
Farmaceutische producten
Vakgebied
Verkoop per activiteit
USD in miljoen | 2018 | Gewicht | 2019 | Gewicht | Delta |
---|---|---|---|---|---|
Cannabis Products
59,3
%
| - | - | 1 | 59,3 % | - |
Patient Network
40,7
%
| - | - | 1 | 40,7 % | - |
Verkoop per regio
USD in miljoen | 2018 | Gewicht | 2019 | Gewicht | Delta |
---|---|---|---|---|---|
Canada
100,0
%
| 0 | nan % | 2 | 100,0 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | - | 26-05-00 | |
Roger Ferreira
CTO | Chief Tech/Sci/R&D Officer | - | 15-12-15 |
Kevin Keagan
BRD | Director/Board Member | - | 24-10-18 |
Grant McLeod
IRO | Public Communications Contact | 46 | 01-07-18 |
Paul Evanov
SAM | Sales & Marketing | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Roger Ferreira
CTO | Chief Tech/Sci/R&D Officer | - | 15-12-15 |
Founder | - | 26-05-00 | |
Kevin Keagan
BRD | Director/Board Member | - | 24-10-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 518 193 558 | 509 860 225 ( 98,39 %) | 0 | 98,39 % |
Bedrijfsgegevens
Beleave, Inc.
2030 Bristol Circle Suite 115
L6H 0H2, Oakville
+
Sector
Verkoop per activiteit
Vaira. 1 jan. | Kapi. | |
---|---|---|
+39,33% | 6,11 mld. | |
-18,38% | 4,35 mld. | |
-9,17% | 3,18 mld. | |
+3,98% | 3,16 mld. | |
-3,41% | 2,51 mld. | |
+48,74% | 1,98 mld. | |
-4,82% | 1,74 mld. | |
-1,24% | 1,63 mld. | |
-8,96% | 1,6 mld. |